It is a healthcare private limited company based in New Delhi, Delhi, India, established in 2001.
2001 | New Delhi, Delhi, India | ActiveAntek Drugs Private Limited, a active private limited company, was established on 14 July 2001 in New Delhi, Delhi, India. Engaging in medical & laboratory equipment within the healthcare sector, it holds CIN: U24232DL2001PTC111537. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Anil Mehta (Director), Dinesh Kakar (Director). Past directors included Lalit Mohan, Amandeep Singh, Anil Mehta. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 913, D-Mall,Netaji Subhash Place Pitampura, New Delhi, Delhi, 110034.
U24232DL2001PTC111537
111537
14 July 2001
₹0.20 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Antek Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anil Mehta | Director | 06 Apr 2015 | Current |
| Dinesh Kakar | Director | 24 Feb 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 Feb 2015 | Past |
| Pramod Abcsdd | Additional Director | 08 Aug 2017 | Past |
| Pramod Abcsdd | Additional Director | 23 Sep 2015 | Past |
| Pramod Abcsdd | Director | 03 Aug 2015 | Past |
| Pramod Abcsdd | Director | 24 Mar 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Antek Drugs Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 56.59% decrease in profit. The company's net worth Soared by an impressive increase of 15.14%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Antek Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Antek Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Antek Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Antek Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Antek Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Antek Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
The activity Anil Mehta was appointed as a Director was appointed as a Director on 06 Apr 2015 & has been associated with this company since 10 years 7 months . was completed.
Dinesh Kakar was appointed as a Director was appointed as a Director on 24 Feb 2015 & has been associated with this company since 10 years 9 months . was recorded as a recent event.
The activity Antek Drugs Private Limited was registered on 14 Jul 2001 with Roc Delhi & aged 24 years 4 months as per MCA records. was completed.
The CIN of Antek Drugs Private Limited is U24232DL2001PTC111537.
Antek Drugs Private Limited is headquartered at 913, D-Mall,Netaji Subhash Place Pitampura, New Delhi, Delhi, 110034.
Antek Drugs Private Limited was incorporated on 14 July 2001.
The current directors of Antek Drugs Private Limited are
The primary industry of Antek Drugs Private Limited is Healthcare.
Antek Drugs Private Limited is unlisted.
The authorized capital of Antek Drugs Private Limited is ₹0.20 M, and the paid-up capital is ₹0.10 M.
The compliance status of Antek Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX